Transcription of 1：日本企業の新薬開発力（1） 主要国別オリジン …
1 2012 12 100 1 IMS World review , Pharma Projects 1 2006 2008 2010 100 2 Annual Report(2011) 1$=80 (2011) Pfizer7,290 Novartis7,666 Merck6,773 2,819 1,898 1,851 1,2514 7,819 (10 ) ( ) 1A 2 PPAR AgII LH-RH DNA AgII HMG-CoAR HMG-CoAR 3 2001 2012 20 ( 8 12 ) 20 1 ( ATL CCR4 2012 ) 19 ( ) (6000 / )
2 80 4 - Nature Reviews Drug Discovery 11 2010 Robert Kneller , , , RCAST 5 FDA NME GMP HTS , etc ( ) , National Institute of Biomedical Innovation3 3 6 in vivo 7 CROCMO ( ) ( ) ( ) GLP GMP CMC CRO CMO 8 ( )
